OncoSec Medical, Inc.
(NASDAQ : ONCS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
NVTAInvitae Corp. 6.77%50.021.4%$138.58m
GHGuardant Health, Inc. 5.34%118.660.0%$117.82m
DVADaVita, Inc. 0.33%109.963.5%$102.73m
SDCSmileDirectClub, Inc. 0.66%12.180.0%$90.42m
ONEM1Life Healthcare, Inc. 3.51%33.630.0%$61.14m
FLGTFulgent Genetics, Inc. 11.29%40.630.7%$60.86m
NTRANatera, Inc. 4.23%88.131.2%$51.91m
CHEChemed Corp. 0.28%473.2610.1%$42.93m
MDMEDNAX, Inc. -1.18%20.1211.1%$42.69m
AMEDAmedisys, Inc. 2.33%240.6711.3%$40.22m
LHCGLHC Group, Inc. 0.78%198.372.9%$35.43m
NEONeoGenomics, Inc. 3.61%47.365.7%$28.88m
ACHCAcadia Healthcare Co., Inc. -0.25%43.1827.1%$26.92m
OTRKOntrak, Inc. 5.90%50.600.0%$24.52m
CRDFCardiff Oncology, Inc. 2.86%21.920.0%$18.43m

Company Profile

OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered inPennington, NJ.